[
  {
    "ts": null,
    "headline": "Should You Reconsider Bristol-Myers After Shares Drop 21% Amid Pharma Tariff Uncertainty?",
    "summary": "So you are staring at Bristol-Myers Squibb's ticker and wondering if now is the time to make a move. When a stock like this shows a long-term downtrend but still dominates conversations in the pharma sector, it's only natural to ask whether the negative sentiment has gone too far. This year alone, shares have slid 20.7%, with a 6.7% decline over the last month and even a dip of 2.6% in the past week. What's driving all the caution, and is Wall Street missing something under the hood? Much of...",
    "url": "https://finnhub.io/api/news?id=b2a06f965301e0b7fab0418d7b213a7aa84e33c3ad6648951a0a137f313fae7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758373562,
      "headline": "Should You Reconsider Bristol-Myers After Shares Drop 21% Amid Pharma Tariff Uncertainty?",
      "id": 136828250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "So you are staring at Bristol-Myers Squibb's ticker and wondering if now is the time to make a move. When a stock like this shows a long-term downtrend but still dominates conversations in the pharma sector, it's only natural to ask whether the negative sentiment has gone too far. This year alone, shares have slid 20.7%, with a 6.7% decline over the last month and even a dip of 2.6% in the past week. What's driving all the caution, and is Wall Street missing something under the hood? Much of...",
      "url": "https://finnhub.io/api/news?id=b2a06f965301e0b7fab0418d7b213a7aa84e33c3ad6648951a0a137f313fae7a"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb: Buy This Deep Bargain Before The Market Wakes To Income",
    "summary": "Bristol Myers Squibb is a strong buy, with a 5.5% yield, growth portfolio, and undervalued shares. See here for more analysis on BMY stock.",
    "url": "https://finnhub.io/api/news?id=bb5c6e7059faf199b272c97929cc98622f870e1273f35d3e5b9500babcbb8ba6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758357000,
      "headline": "Bristol Myers Squibb: Buy This Deep Bargain Before The Market Wakes To Income",
      "id": 136827208,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126636461/image_1126636461.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol Myers Squibb is a strong buy, with a 5.5% yield, growth portfolio, and undervalued shares. See here for more analysis on BMY stock.",
      "url": "https://finnhub.io/api/news?id=bb5c6e7059faf199b272c97929cc98622f870e1273f35d3e5b9500babcbb8ba6"
    }
  }
]